Cardiac amyloidosis is a rare. debilitating. and usually fatal disease increasingly recognized in clinical practice despite patients presenting with non-specific symptoms of cardiomyopathy. The current standard of care (SoC) focuses on preventing further amyloid formation and deposition. https://www.diwalishare.com/product-category/compliance-labels/